Apex Science & Engineering Corp.
TWSE:3052.TW
13.85 (TWD) • At close July 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,484.066 | 2,951.661 | 3,614.744 | 5,217.591 | 5,623.832 | 1,070.737 | 3,901.472 | 2,887.603 | 2,514.096 | 3,691.612 | 8,176.431 | 3,830.002 | 5,336.183 | 2,600.168 | 2,919.897 |
| Cost of Revenue
| 3,096.15 | 2,584.45 | 3,409.834 | 4,732.188 | 5,233.282 | 1,136.162 | 3,458.417 | 2,721.77 | 2,212.424 | 3,252.408 | 6,428.915 | 3,404.437 | 4,898.18 | 2,067.404 | 2,196.434 |
| Gross Profit
| 387.916 | 367.211 | 204.91 | 485.403 | 390.55 | -65.425 | 443.055 | 165.833 | 301.672 | 439.204 | 1,747.516 | 425.565 | 438.003 | 532.764 | 723.463 |
| Gross Profit Ratio
| 0.111 | 0.124 | 0.057 | 0.093 | 0.069 | -0.061 | 0.114 | 0.057 | 0.12 | 0.119 | 0.214 | 0.111 | 0.082 | 0.205 | 0.248 |
| Reseach & Development Expenses
| 2.027 | 2.751 | 1.831 | 2.622 | 3.388 | 3.579 | 3.375 | 3.528 | 2.873 | 2.551 | 2.973 | 3.74 | 7.227 | 6.369 | 7.058 |
| General & Administrative Expenses
| 123.643 | 117.958 | 98.042 | 118.324 | 113.25 | 100.238 | 126.809 | 95.702 | 103.169 | 127.039 | 187.422 | 143.594 | 145.275 | 144.683 | 154.042 |
| Selling & Marketing Expenses
| 40.567 | 37.791 | 36.98 | 76.032 | 34.346 | 35.127 | 44.441 | 21.688 | 48.977 | 76.525 | 313.622 | 71.458 | 68.177 | 92.525 | 131.105 |
| SG&A
| 164.21 | 155.749 | 135.022 | 194.356 | 147.596 | 135.365 | 171.25 | 117.39 | 152.146 | 203.564 | 501.044 | 215.052 | 213.452 | 237.208 | 285.147 |
| Other Expenses
| -166.237 | 20.652 | 0.641 | 11.678 | 15.948 | 17.826 | -6.79 | 20.62 | 24.186 | 18.704 | 34.658 | 6.974 | 8.334 | -52.387 | 2.377 |
| Operating Expenses
| 166.237 | 158.5 | 136.853 | 196.978 | 150.984 | 138.944 | 174.625 | 120.918 | 155.019 | 206.115 | 504.017 | 218.792 | 220.679 | 243.577 | 292.205 |
| Operating Income
| 221.679 | 293.349 | 160.906 | 336.16 | 277.444 | -204.369 | 268.43 | 44.915 | 146.653 | 233.089 | 1,243.499 | 206.773 | 217.324 | 289.187 | 431.258 |
| Operating Income Ratio
| 0.064 | 0.099 | 0.045 | 0.064 | 0.049 | -0.191 | 0.069 | 0.016 | 0.058 | 0.063 | 0.152 | 0.054 | 0.041 | 0.111 | 0.148 |
| Total Other Income Expenses Net
| 51.571 | -17.826 | -21.758 | -27.832 | -33.46 | 0.474 | -35.593 | -3.628 | -5.026 | -3.663 | 7.858 | -22.645 | -0.92 | -60.942 | -1.204 |
| Income Before Tax
| 273.25 | 275.523 | 139.148 | 308.328 | 243.984 | -203.895 | 232.837 | 41.287 | 141.627 | 229.426 | 1,251.357 | 184.128 | 216.404 | 228.245 | 430.054 |
| Income Before Tax Ratio
| 0.078 | 0.093 | 0.038 | 0.059 | 0.043 | -0.19 | 0.06 | 0.014 | 0.056 | 0.062 | 0.153 | 0.048 | 0.041 | 0.088 | 0.147 |
| Income Tax Expense
| 66.074 | 67.109 | 33.141 | -14.127 | 66.698 | -68.751 | 24.275 | -11.513 | 3.755 | 50.35 | -9.354 | 6.62 | 28.529 | 44.535 | -10.959 |
| Net Income
| 204.792 | 206.934 | 102.741 | 315.653 | 175.432 | -135.918 | 200.804 | 44.479 | 142.753 | 185.708 | 1,252.948 | 179.784 | 179.268 | 178.767 | 451.231 |
| Net Income Ratio
| 0.059 | 0.07 | 0.028 | 0.06 | 0.031 | -0.127 | 0.051 | 0.015 | 0.057 | 0.05 | 0.153 | 0.047 | 0.034 | 0.069 | 0.155 |
| EPS
| 1.04 | 1.03 | 0.51 | 1.56 | 0.86 | -0.68 | 1 | 0.22 | 0.7 | 0.91 | 6.12 | -0.24 | 0.87 | 0.87 | 2.45 |
| EPS Diluted
| 1.03 | 1.02 | 0.5 | 1.54 | 0.86 | -0.68 | 0.99 | 0.22 | 0.7 | 0.9 | 6.08 | -0.24 | 0.87 | 0.87 | 2.45 |
| EBITDA
| 308.364 | 304.334 | 170.948 | 343.063 | 284.734 | -163.14 | 279.139 | 91.267 | 190.746 | 272.358 | 1,298.806 | 238.625 | 253.119 | 249.673 | 453.068 |
| EBITDA Ratio
| 0.089 | 0.103 | 0.047 | 0.066 | 0.051 | -0.152 | 0.072 | 0.032 | 0.076 | 0.074 | 0.159 | 0.062 | 0.047 | 0.096 | 0.155 |